Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Prostatic Neoplasms 6Head and Neck Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Gliosarcoma 4Nasopharyngeal Carcinoma 3Urinary Bladder Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Glioma 2Congenital Abnormalities 2Carcinoma, Squamous Cell 2Breast Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Tongue Neoplasms 1Rectal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Lung Neoplasms 1Liver Neoplasms 1Esophageal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1

Interventions

Cytarabine 12Peripheral Blood Stem Cell Transplantation 10fludarabine phosphate 7Cyclosporine 7Mycophenolic Acid 6Busulfan 6Methotrexate 5Melphalan 4Idarubicin 4Filgrastim 4Etoposide 4Clofarabine 4aldesleukin 3Whole-Body Irradiation 3Tacrolimus 3Radiotherapy 3Mitoxantrone 3Flow Cytometry 3Daunorubicin 3Cyclophosphamide 3Antilymphocyte Serum 3Transplantation 2Radiotherapy, Intensity-Modulated 2Interleukin-2 2Granulocyte Colony-Stimulating Factor 2Cytogenetic Analysis 2Bortezomib 2Alemtuzumab 2tipifarnib 1liposomal doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Congenital Abnormalities × Radiotherapy, Intensity-Modulated × Clear all
NCT00544466 2026-02-19

Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

City of Hope Medical Center

Phase 1/2 Active not recruiting
75 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00540995 2023-11-30

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

City of Hope Medical Center

Phase 1/2 Terminated
25 enrolled 9 charts
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡